SCHEMBL23331024

SCHEMBL23331024

O=C1CCCN1c1cnc(O)nc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CNR2 P34972 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HPGD P15428 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ ALOX5AP P20292 1/20 0.34
▸ FEN1 P39748 1/20 0.34
▸ CYP11B2 P19099 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23331023 0.71 HSD17B10 (0.40) ALDH1A1HSD17B10L3MBTL1CNR2HTR6
SCHEMBL23330864 0.67 CNR2 (0.36) ALDH1A1HSD17B10L3MBTL1CNR2HTR6
SCHEMBL23331022 0.66 HSD17B10 (0.38) ALDH1A1HSD17B10L3MBTL1CNR2HTR6
SCHEMBL29527139 0.66 HSD17B10 (0.41) ALDH1A1HSD17B10L3MBTL1TSHRHPGD
SCHEMBL29066214 0.66 HSD17B10 (0.41) ALDH1A1HSD17B10L3MBTL1TSHRHPGD
SCHEMBL6763593 0.66 ADRA1B (0.49) ALDH1A1HSD17B10L3MBTL1MEN1TSHR
SCHEMBL30094610 0.66 HSD17B10 (0.51) HSD17B10L3MBTL1CNR2MEN1TSHR
SCHEMBL23833638 0.66 HSD17B10 (0.51) HSD17B10L3MBTL1CNR2MEN1TSHR
SCHEMBL2645643 0.66 CNR2 (0.56) ALDH1A1L3MBTL1CNR2KMT2AHPGD
SCHEMBL6576703 0.64 L3MBTL1 (0.47) ALDH1A1HSD17B10L3MBTL1MEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230028221-A1 EED INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF JING MEDICINE TECHNOLOGY (SHANGHAI) LTD. (CN) 2023-01-26 — — US disclosed
WO-2021083380-A1 EED INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海科技大学 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230028221-A1 EED INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF CYP4F11, CYP4A11, HSD11B1 ALDH1A1 650/4885HSD17B10 332/4885L3MBTL1 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback